Clinical trial
Role of Butyrophilins in Colon Cancers Aggressiveness Evaluation
NCT04185272 is registered in ClinicalTrials.gov with Institut Paoli-Calmettes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Butyrophilins in Colon Cancers Aggressiveness Evaluation
- Lead sponsor
- Institut Paoli-Calmettes
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 30, 2020
- Completion date
- June 30, 2028
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colonic cancer